Neometeoryl Transruminal & Oral Solution

28 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.

Total Reports

Deaths Reported

360.0%

Death Rate

Active Ingredients

Neometeoryl Transruminal & Oral Solution

Administration Routes

UnknownOralAuricular (Otic)SubcutaneousOtherNasal

Species Affected

Dog 22

Cat 6

Most Affected Breeds

Retriever - Labrador 7

Domestic Shorthair 6

Rottweiler 4

Unknown 3

Terrier (unspecified) 2

Collie - Border 1

Portuguese Water Dog 1

Spitz - German Pomeranian 1

Shepherd Dog - German 1

Pit Bull 1

Most Reported Reactions

Vomiting 7

Low platelet count 6

Decreased appetite 5

Lethargy (see also Central nervous system depression in 'Neurological') 5

Cough 4

Oral cavity disorder NOS 4

Oral pain 4

Eosinophilia 4

Elevated serum alkaline phosphatase (SAP) 4

Myositis 4

Elevated creatinine 4

Fever 4

Outcome Breakdown

Outcome Unknown

17 (60.7%)

Recovered/Normal

7 (25.0%)

Ongoing

2 (7.1%)

Recovered with Sequela

1 (3.6%)

Euthanized

1 (3.6%)

Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.